Jayasuriya Anula bought LCTX
July 1, 2025 · Form 4 insider transaction
Jayasuriya Anula bought 75,000 shares of Lineage Cell Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderJayasuriya Anula
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 1, 2025
Filing dateJuly 2, 2025
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Will vest and become exercisable on the earlier of July 1, 2026 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer.